These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23517420)

  • 1. Genomics in the assessment of a multi-component, multi-target medication in soft tissue disorders.
    St Laurent G; Kapranov P
    Curr Med Res Opin; 2013; 29 Suppl 2():11-4. PubMed ID: 23517420
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammation in soft tissue disorders: the evidence and potential role for a natural multi-target medication.
    Wolfarth B; de Vega CG; Kapranov P; St Laurent G; Speed C
    Curr Med Res Opin; 2013; 29 Suppl 2():1-2. PubMed ID: 23517417
    [No Abstract]   [Full Text] [Related]  

  • 3. Make an impact on your daily practice: the potential role for a natural multi-target medication.
    Wolfarth B; González de Vega C
    Curr Med Res Opin; 2013; 29 Suppl 2():15-9. PubMed ID: 23517421
    [No Abstract]   [Full Text] [Related]  

  • 4. Improving lead generation success through integrated methods: transcending 'drug discovery by numbers'.
    Campbell JB
    IDrugs; 2010 Dec; 13(12):874-9. PubMed ID: 21154146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical screening in zebrafish for novel biological and therapeutic discovery.
    Tan JL; Zon LI
    Methods Cell Biol; 2011; 105():493-516. PubMed ID: 21951544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of genomics and proteomics in drug target discovery.
    Zhang HM; Nan ZR; Hui GQ; Liu XH; Sun Y
    Genet Mol Res; 2014 Jan; 13(1):198-204. PubMed ID: 24446303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on ion channel transporters as a target for the drug discovery].
    Imaizumi Y; Kaneko S
    Nihon Yakurigaku Zasshi; 2011 Dec; 138(6):227. PubMed ID: 22303567
    [No Abstract]   [Full Text] [Related]  

  • 8. Project ranks billions of drug interactions.
    Reardon S
    Nature; 2013 Nov; 503(7477):449-50. PubMed ID: 24284710
    [No Abstract]   [Full Text] [Related]  

  • 9. Model-based drug discovery: implementation and impact.
    Visser SA; Aurell M; Jones RD; Schuck VJ; Egnell AC; Peters SA; Brynne L; Yates JW; Jansson-Löfmark R; Tan B; Cooke M; Barry ST; Hughes A; Bredberg U
    Drug Discov Today; 2013 Aug; 18(15-16):764-75. PubMed ID: 23726890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved preclinical safety assessment using micro-BAL devices: the potential impact on human discovery and drug attrition.
    Giri S; Bader A
    Drug Discov Today; 2011 May; 16(9-10):382-97. PubMed ID: 21354326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtractive genomics approach to identify putative drug targets and identification of drug-like molecules for beta subunit of DNA polymerase III in Streptococcus species.
    Georrge JJ; Umrania VV
    Appl Biochem Biotechnol; 2012 Jul; 167(5):1377-95. PubMed ID: 22415782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current trends in epigenetic drug discovery.
    Stolfa DA; Einsle O; Sippl W; Jung M
    Future Med Chem; 2012 Oct; 4(16):2029-37. PubMed ID: 23157236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turning genetic discoveries into new treatments: the Wnt/LRP-5 system as a source of new drug targets for skeletal diseases.
    Bodine PV
    J Musculoskelet Neuronal Interact; 2008; 8(4):296-7. PubMed ID: 19147946
    [No Abstract]   [Full Text] [Related]  

  • 14. Meeting the demands of regulatory requirements: the significance of ADME.
    Guttendorf R
    Bioanalysis; 2012 Jun; 4(12):1395-7. PubMed ID: 22793021
    [No Abstract]   [Full Text] [Related]  

  • 15. How has the genomics era impacted schistosomiasis drug discovery?
    Oliveira G; Pierce RJ
    Future Med Chem; 2015; 7(6):685-7. PubMed ID: 25996060
    [No Abstract]   [Full Text] [Related]  

  • 16. New roles for structure in biology and drug discovery.
    Russell RB; Eggleston DS
    Nat Struct Biol; 2000 Nov; 7 Suppl():928-30. PubMed ID: 11103989
    [No Abstract]   [Full Text] [Related]  

  • 17. Small molecules and their role in effective preclinical target validation.
    Clegg MA; Tomkinson NC; Prinjha RK; Humphreys PG
    Future Med Chem; 2017 Sep; 9(14):1579-1582. PubMed ID: 28828889
    [No Abstract]   [Full Text] [Related]  

  • 18. From fragment to clinical candidate--a historical perspective.
    Chessari G; Woodhead AJ
    Drug Discov Today; 2009 Jul; 14(13-14):668-75. PubMed ID: 19427404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in physicochemical and ADMET profiling in drug discovery.
    Wang J; Skolnik S
    Chem Biodivers; 2009 Nov; 6(11):1887-99. PubMed ID: 19937823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted scoring functions for virtual screening.
    Seifert MH
    Drug Discov Today; 2009 Jun; 14(11-12):562-9. PubMed ID: 19508918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.